Pular para o conteúdo principal
  • Portal do Governo Brasileiro
  • Atualize sua Barra de Governo
Início
Buscar: Pesquisador(a) | Publicação
Portuguese Chinese (Simplified) English French German Korean Russian Spanish Swahili Yoruba

Menu principal

  • PESQUISADORES
  • REVISTAS
  • ASSUNTOS
  • PUBLICAÇÕES
Início Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism

Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism

Título: 
Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism
Autor: 
Márcia Rodrigues Amorim
Ano: 
2020
DOI: 
10.1186/s12885-020-06802-8
Revista: 
BMC CANCER
ISSN: 
14712407
Idioma: 
Inglês
Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Non-Latin European descent could be a requirement for association of NTDs andMTHFR variant 677C?>?T: A meta-analysis
Association of methylenetetrahydrofolate reductase gene 677C > T polymorphism and Down syndrome
Dihydrofolate reductase (DHFR) del19bp polymorphism and Down syndrome offspring
Estudo do polimorfismo 609C>T no gene NQO1 em leucemias agudas pediátricas.
66A>G Polymorphism as Maternal Risk Factor for Down Syndrome: A Meta-Analysis
Possible Pleiotropic Effect of SRY Gene May Increase Male Susceptibility to COVID-19
DNA extraction from fixed cytogenetic cell suspensions
No association of the polyhistidine tract polymorphism of the ZIC2 gene with neural tube defects in a South American (ECLAMC) population
Efficient DNA Extraction Protocol for Single Nucleotide Polymorphisms Genotyping in Down Syndrome
Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2
  •  
  • 1 de 3
  • próximo ›

Sobre o site | Fale conosco

Versão Alpha. As informações contidas neste site foram importadas do Lattes no dia 20/04/2022.